Groundbreaking cancer drug enters first human trials
Disease control
Completed
This completed Phase 1 trial tested the safety of a new oral drug called Karonudib in 63 adults with advanced solid tumors. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers also looked for early signs that the drug might …
Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC